AIMI: AIM ImmunoTech Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) -1.32
Book Value / Share -0.02
Price / Book n/a
NCAV ($M) -5.75
NCAV / Share -0.08
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -9.85
Return on Assets (ROA) -1.07
Return on Equity (ROE) -3.59

Liquidity (mrq)
Quick Ratio 0.44
Current Ratio 0.44

Balance Sheet (mrq) ($M)
Current Assets 4.18
Assets 8.61
Liabilities 9.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.17
Operating Income -19.77
Net Income -17.32
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -14.89
Cash from Investing 4.71
Cash from Financing 6.44

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
AGTX – Agentix Corp. AHRO – Authentic Holdings, Inc.
AIBT – Aibotics Inc. AKBLF – ALK-Abelló A/S
AMBS – Amarantus BioScience Holdings, Inc.


Financial data and stock pages provided by
Fintel.io